Who owns MIRUM PHARMACEUTICALS INC NOTE 4.000 5/0?
- CUSIP Number: 604749ab7
Tip: Access positions for across all investors
Analyze quarterly positions in Mirum Pharmaceuticals Inc Note 4.000 5/0 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mirum Pharmaceuticals Inc Note 4.000 5/0 stock
Who bought or sold MIRUM PHARMACEUTICALS INC NOTE 4.000 5/0 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 70M | $209M | 0% | Mar 2026 |
|
| Tenor Capital Management | 44M | $132M | 53% | Mar 2026 |
|
| Readystate Asset Management | 28M | $84M | -8% | Mar 2026 |
|
| Capstone Investment Advisors | 27M | $81M | 12% | Mar 2026 |
|
| MacKay Shields | 23M | $69M | -10% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 22M | $67M | -24% | Mar 2026 |
|
| Polar Securities | 21M | $64M | 0% | Mar 2026 |
|
| Lazard Asset Management | 12M | $354k | 3% | Mar 2026 |
|
| Point72 Asset Management | 9.4M | $28M | 0% | Mar 2026 |
|
| Lord, Abbett & Co | 6.2M | $19M | 5% | Mar 2026 |
|
| FMR | 6.1M | $16M | 0% | Dec 2025 |
|
| Aequim Alternative Investments | 6.0M | $16M | 0% | Dec 2025 |
|
| BlackRock | 5.2M | $15M | 28% | Mar 2026 |
|
| SSI Investment Management | 3.3M | $9.7M | -21% | Mar 2026 |
|
| Nicholas Investments Partners | 2.3M | $5.8M | -25% | Dec 2025 |
|
| Bank Of Montreal | 2.0M | $6.0M | 100% | Mar 2026 |
|
| Linden Advisors | 2.0M | $5.2M | 0% | Dec 2025 |
|
| Franklin Resources | 1.9M | $5.6M | 0% | Mar 2026 |
|
| Advent Capital Management | 1.4M | $4.2M | 2% | Mar 2026 |
|
| Invesco | 1.1M | $3.3M | -56% | Mar 2026 |
|
| Kornitzer Capital Management | 1.0M | $3.0M | -9% | Mar 2026 |
|
| Wells Fargo & Company | 521k | $1.6M | -1% | Mar 2026 |
|
| Agf Management | 500k | $1.5M | -29% | Mar 2026 |
|
| Barclays | 373k | $968k | 4% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 244k | $730k | 0% | Mar 2026 |
|
| Sei Investments | 228k | $680k | 0% | Mar 2026 |
|
| Morgan Stanley | 200k | $596k | 100% | Mar 2026 |
|
| Central Pacific Bank - Trust Division | 125k | $373k | 0% | Mar 2026 |
|
| Citigroup | 115k | $343k | 100% | Mar 2026 |
|
| UBS Group | 91k | $270k | 13433% | Mar 2026 |
|
| Oppenheimer Asset Management | 63k | $188k | -2% | Mar 2026 |
|
| Calamos Advisors | 47k | $141k | 15% | Mar 2026 |
|
| Stephens | 20k | $60k | 0% | Mar 2026 |
|
| Virtus ETF Advisers | 18k | $54k | 0% | Mar 2026 |
|
| Balboa Wealth Partners | 10k | $30k | 0% | Mar 2026 |
|
| Goss Wealth Management | 10k | $10k | 0% | Mar 2026 |
|
Who sold out of Mirum Pharmaceuticals Inc Note 4.000 5/0?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 18M | $48M |
| Aristeia Capital | Dec 2025 | 3.0M | $7.8M |
| Universal- Beteiligungs- und Servicegesellschaft mbH | Dec 2025 | 363k | $939k |
| Ares Systematic Credit | Dec 2025 | 100k | $259k |